找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment; Roberto L. Ceriani Book 1994 The Editor(s) (if applic

[復(fù)制鏈接]
樓主: 實(shí)體
21#
發(fā)表于 2025-3-25 03:58:38 | 只看該作者
22#
發(fā)表于 2025-3-25 08:57:07 | 只看該作者
23#
發(fā)表于 2025-3-25 15:26:36 | 只看該作者
Breast Mucin and Associated Antigens in Diagnosis and Therapy,mucin by disulfide linkages, suggesting it to be a putative linker protein (Duwe et al., 1989) for the breast mucin. The 46 kDa glycoprotein (BA46) appears to be a member of a family of proteins having a domain with homology with the C1C2 domain of human coagulation factors V and VIII (Larocca et al
24#
發(fā)表于 2025-3-25 18:26:08 | 只看該作者
25#
發(fā)表于 2025-3-25 21:12:20 | 只看該作者
26#
發(fā)表于 2025-3-26 01:54:08 | 只看該作者
Engineering of Antibodies for Breast Cancer Therapy: Construction of Chimeric and Humanized Versionwever, displace good murine antibodies that have resulted from years of arduous labor and minutious characterization since these murine antibodies may have uniquely useful binding properties, and since they can be humanized.
27#
發(fā)表于 2025-3-26 04:40:46 | 只看該作者
28#
發(fā)表于 2025-3-26 09:04:19 | 只看該作者
The Use of Monoclonal Antibody Immunoconjugates in Cancer Therapy, IL-2) and other moieties have been used; these have been reviewed elsewhere.. At this time, there is some pessimism regarding the value of antibody immunoconjugates for the therapy of cancer, and at the outset we would like to dispel this pessimism for the following reasons: a) few, if any trials h
29#
發(fā)表于 2025-3-26 12:38:49 | 只看該作者
https://doi.org/10.1007/978-3-322-90618-2mucin by disulfide linkages, suggesting it to be a putative linker protein (Duwe et al., 1989) for the breast mucin. The 46 kDa glycoprotein (BA46) appears to be a member of a family of proteins having a domain with homology with the C1C2 domain of human coagulation factors V and VIII (Larocca et al
30#
發(fā)表于 2025-3-26 17:44:38 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-27 05:31
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
福鼎市| 景德镇市| 托里县| 灵璧县| 锡林浩特市| 科尔| 赞皇县| 甘谷县| 吴忠市| 菏泽市| 班戈县| 阳城县| 中卫市| 安西县| 石家庄市| 馆陶县| 安阳县| 蒙阴县| 宝坻区| 呼玛县| 夏邑县| 延津县| 汪清县| 夏津县| 溧阳市| 绥中县| 揭阳市| 望都县| 北川| 东乡县| 高雄市| 综艺| 观塘区| 富裕县| 阳泉市| 财经| 马山县| 彰化市| 宣化县| 当阳市| 宾阳县|